Christine Sauvage

Efficacy and safety of oral immunotherapy with AR101 in European children with a peanut allergy (ARTEMIS): a multicentre, double-blind, randomised, placebo-controlled phase 3 trial

Jonathan O’B Hourihane, Kirsten Beyer, Allyah Abbas‐Hanif et al. · The Lancet Child & Adolescent Health · 2020 · 158 citations

Life Sciences, Immunology, Pediatrics +14

Intestinal permeability and fecal eosinophil-derived neurotoxin are the best diagnosis tools for digestive non-IgE-mediated cow’s milk allergy in toddlers

Nicolas Kalach, Nathalie Kapel, Anne‐Judith Waligora‐Dupriet et al. · Clinical Chemistry and Laboratory Medicine (CCLM) · 2012 · 60 citations

Medicine, Immunology, Pediatrics +17

Phenotypical characterization of peanut allergic children with differences in cross‐allergy to tree nuts and other legumes

M. Cousin, Stéphane Verdun, M. Seynave et al. · Pediatric Allergy and Immunology · 2017 · 45 citations

Medicine, Immunology, Pediatrics +17

Epicutaneous Immunotherapy (EPIT) Is Effective and Safe to Treat Peanut Allergy: A Multi-National Double-Blind Placebo-Controlled Randomized Phase IIb Trial

Hugh A. Sampson, Wence Agbotounou, Claude Thébault et al. · Journal of Allergy and Clinical Immunology · 2015 · 29 citations

Life Sciences, Immunology, Pharmacology +13

Peanut Epicutaneous Immunotherapy (EPIT) In Peanut-Allergic Children: 18 Months Treatment In The Arachild Study

Christophe Dupont, T. Bourrier, F. de Blay et al. · Journal of Allergy and Clinical Immunology · 2014 · 27 citations

Life Sciences, Child Health, Pediatrics +13